RT Journal Article
SR Electronic
A1 Gordon, Debra
T1 High-Dose Clopidogrel in Patients with High Residual Reactivity: Results from the GRAVITAS Trial
JF MD Conference Express
YR 2010
FD SAGE Publications
VO 10
IS 10
SP 19
OP 20
DO 10.1177/155989771010012
UL http://mdc.sagepub.com/content/10/10/19.abstract
AB Doubling the dose of clopidogrel in patients with high residual platelet activity after percutaneous intervention has no significant effect on cardiovascular outcomes, according to the neutral results of the Gauging Responsiveness with A VerifyNow Assay—Impact on Thrombosis And Safety [GRAVITAS; NCT00645918] trial.